Systemic Inflammatory Response Induces Multi-Organ Damage After Cardiac Arrest Through IL-17 Pathway in Animal Models - Report - MDSpire

Systemic Inflammatory Response Induces Multi-Organ Damage After Cardiac Arrest Through IL-17 Pathway in Animal Models

  • By

  • Yang Yan

  • Taiwei Chen

  • Ancai Yuan

  • Na Geng

  • Fang Wan

  • Peiliang Fang

  • Zhiqing Qiao

  • Zhaoling Wei

  • Jun Pu

  • April 29, 2026

  • 0 min

Share

Clinical Report: Systemic Inflammatory Response Induces Multi-Organ Damage After Cardiac Arrest

Overview

This study identifies the IL-17 signaling pathway as a key mediator of systemic inflammation and multi-organ dysfunction following cardiac arrest. Early inhibition of IL-17A significantly improves outcomes in animal models, suggesting a potential therapeutic target for post-cardiac arrest syndrome.

Background

Post-cardiac arrest syndrome (PCAS) is a serious condition characterized by multi-organ dysfunction following resuscitation. Understanding the inflammatory mechanisms involved in PCAS is crucial, as systemic inflammation can lead to prolonged organ injury and poor long-term outcomes. Identifying specific inflammatory mediators, such as IL-17A, may provide insights into potential therapeutic strategies.

Data Highlights

OutcomeEffect of IL-17A Inhibition
Left Ventricular Ejection FractionImproved
Neuronal ApoptosisReduced
72-Hour SurvivalImproved

Key Findings

  • IL-17 signaling pathway is activated early after cardiac arrest/cardiopulmonary resuscitation (CA/CPR).
  • IL-17A levels are significantly elevated in patients post-cardiac arrest compared to controls.
  • Inhibition of IL-17A with secukinumab improves myocardial and cerebral function in animal models.
  • Early pharmacological intervention targeting IL-17A may reduce systemic inflammation and multi-organ injury.
  • Persistent inflammation post-resuscitation contributes to prolonged organ dysfunction.

Clinical Implications

Targeting IL-17A may offer a novel therapeutic approach to mitigate systemic inflammation and improve outcomes in patients experiencing post-cardiac arrest syndrome. Clinicians should consider the role of inflammatory mediators in managing multi-organ dysfunction following cardiac arrest.

Conclusion

The findings underscore the importance of the IL-17A pathway in the inflammatory response after cardiac arrest, highlighting its potential as a therapeutic target to improve patient outcomes in post-cardiac arrest syndrome.

References

  1. Basic Research in Cardiology, 2021 -- Investigating the Impact of Remote Ischaemic Conditioning on Inflammation: Insights into Innate Immunity and Cytokine Activity
  2. The Journal of Infectious Diseases, 2022 -- Cytokine Profiles Distinguish Acute and Recovery Phases of Cardiac Involvement Following COVID-19: A Multicohort Biomarker Analysis
  3. Basic Research in Cardiology, 2013 -- Synthetic CpG-oligonucleotide Pre-conditioning Reduces Myocardial Ischemia/Reperfusion Injury Through IL-10 Enhancement
  4. Basic Research in Cardiology, 2016 -- Mesenchymal Stem Cells Reduce Inflammation in Cardiac and Pulmonary Tissues by Targeting TNF Signaling Pathways
  5. American Heart Association CPR & First Aid, 2024 -- Part 11: Post-Cardiac Arrest Care
  6. Biomarkers in Cardiac Arrest: A Narrative Review - PMC
  7. Part 11: Post-Cardiac Arrest Care | American Heart Association CPR & First Aid
  8. Biomarkers in Cardiac Arrest: A Narrative Review - PMC

Original Source(s)

Related Content